semaglutide ficha tecnica Disponible en España semaglutida 2,4 mg, fármaco que permite controlar el peso Once-Weekly Subcutaneous Semaglutide 2.4 mg

Semaglutide is a GLP-1 receptor agonist that helps manage weight by improving insulin regulation, suppressing appetite, and slowing gastric emptying

Mojsov, Weir, and Habener reported in 1987 that GLP-1(7-37), a cleavage product of proglucagon expressed in intestinal L-cells, stimulated insulin secretion from the perfused rat pancreas at picomolar concentrations [2]

As a result, patients feel fuller sooner and eat less overall

Participants (mean age 42.4, mean baseline glycated hemoglobin [HbA1c] 8.02%, mean baseline weight 90.47 kg, and mean baseline BMI 32.98 kg/m) received mazdutide 6 mg or semaglutide 1 mg for 32 weeks

Schulz-Schaeffer, W.J

Lixisenatida presenta un efecto sinrgico con metformina y permite un estricto control glucmico precoz sin la presencia de hipoglucemias, asociando a este efecto una reduccin ponderal significativa, no objetivada en tratamiento combinado de metformina con sulfonilureas o pioglitazona(14)